baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

KYOWA KIRIN CO. LTD./ JP3256000005 /

2024-11-13 3:29:02 PM	Chg. -0.3000	Volume	Bid4:14:04 PM	Ask3:29:03 PM	Market Capitalization	Dividend Y.	P/E Ratio
14.7000EUR	-2.00%	0 Turnover: 0.0000	-Bid Size: -	-Ask Size: -	8.42 bill.EUR	-	-

GlobeNewswire 08-28 Orchard Therapeutics Announces Multiple Presentations from across its Late-stage Neurometabolic Port...

GlobeNewswire 08-08 Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer

GlobeNewswire 08-01 Ultragenyx Reports Second Quarter 2024 Financial Results and Corporate Update

GlobeNewswire 08-01 Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 08-01 BridgeBio Pharma Reports Second Quarter 2024 Financial Results and Business Update

GlobeNewswire 08-01 Pharming Group reports second quarter and first half 2024 financial results and provides business up...

GlobeNewswire 07-31 Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Tri...

GlobeNewswire 07-18 Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024

GlobeNewswire 07-17 Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinical...

GlobeNewswire 07-02 To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA

GlobeNewswire 06-28 Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Heal...

GlobeNewswire 06-28 Orchard Therapeutics Celebrates Global Progress toward Advancing Newborn Screening for MLD on Intern...

GlobeNewswire 06-13 Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors

GlobeNewswire 05-30 Ardelyx, Inc. Reports Employment Inducement Grants

GlobeNewswire 05-23 Hornet Therapeutics emerges from stealth with data published in Science demonstrating the first pote...

GlobeNewswire 05-22 Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference

GlobeNewswire 05-21 Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapano...

GlobeNewswire 05-16 Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)

GlobeNewswire 05-15 Lantheus Announces Executive Appointments to Accelerate Innovation

GlobeNewswire 05-14 Ardelyx, Inc. Reports Employment Inducement Grants

GlobeNewswire 05-08 Pharming Group reports first quarter 2024 financial results and provides business update

GlobeNewswire 05-07 Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Ir...

GlobeNewswire 05-07 Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024

GlobeNewswire 05-03 Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024...

GlobeNewswire 05-02 Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update

KYOWA KIRIN CO. LTD./ JP3256000005 /

If you wish to receive reply to your feedback, please provide your email address.